Description
ITPP + SR-9009 (Stenabolic) Tablets research stack
ITPP + SR-9009 Tablets combine ITPP, an allosteric haemoglobin effector, with SR-9009 (Stenabolic), a Rev-Erb agonist.
Product details
| Compound | ITPP and SR-9009 |
|---|---|
| Class | Two-compound tablet formula |
| From | Tablets |
| Strength | 70mg per tab/27ct/1890mg; 70mg per tab/54ct/3780mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- ITPP: haemoglobin oxygen release.
- SR-9009: circadian research.
- Combination research.
Research interest does not establish a proven effect in humans.
Regulatory status
This is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Independent literature: search PubMed for published studies.
Related research products
ITPP + SR-9011 Tablets · DHEA + Enclomiphene Citrate Stack · Noopept + NAD + Stack · All nootropic tablets
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.